Myrna, Author at CDMO World

Quality Agreements Between Sponsors and CDMOs: Key Clauses to Include

Establishing robust quality agreements pharma cdmo is a regulatory necessity that defines the division of responsibilities between sponsors and manufacturers. This 2500-word guide explores essential clauses, from audit rights to deviation management, ensuring your partnership meets FDA and EMA standards. Learn how to mitigate risk and protect your product's integrity through strategic documentation.

Legal and Regulatory
Biosimilar Manufacturing Challenges: Why CDMO Partnerships Matter

Developing biosimilars requires navigating a labyrinth of technical and regulatory hurdles. This comprehensive guide examines the most pressing biosimilar manufacturing challenges, from analytical characterization to large-scale production. Discover how strategic CDMO partnerships provide the specialized expertise and infrastructure necessary to achieve analytical biosimilarity and commercial success.

Biotech
Contract Manufacturing for Sterile Injectables: What Sponsors Need to Know

Navigating the complexities of contract manufacturing sterile injectables requires a deep understanding of aseptic processing, fill-finish technology, and rigorous GMP compliance. This 2500-word guide provides sponsors with essential insights into selecting the right CDMO, managing technical transfers, and ensuring sterility assurance for high-value biologic and small molecule injectables.

Manufacturing and Operations
CDMO Strategies for Drug-Device Combination Products: Navigating FDA Regulatory Pathways

Navigating the regulatory landscape for drug device combination products requires a dual focus on pharmaceutical and medical device standards. This comprehensive 2500-word guide explores CDMO strategies for managing FDA 21 CFR Part 4 requirements, risk management (ISO 14971), and human factors engineering. Learn how to optimize your submission strategy and ensure market success for innovative combination therapies.

Medical Technology
Medical Device CDMO Supplier Qualification Checklist: What FDA Inspectors Expect

Navigating the complexities of medical technology requires a robust CDMO supplier qualification checklist. This 2500-word guide explores what FDA inspectors expect during audits, covering quality management systems, risk mitigation, and technical validation. Learn how to secure your supply chain and maintain regulatory excellence in the evolving medical device manufacturing landscape.

Medical Technology
Transferring Medical Device Manufacturing to a CDMO: FDA Requirements and Common Pitfalls

Moving production to a CDMO requires precision. This 2500-word guide covers the medical device manufacturing transfer process, FDA 21 CFR 820 rules, and how to avoid documentation gaps and validation failures for medtech leaders.

Medical Technology
Serialization and Track‑and‑Trace in the Pharmaceutical Supply Chain

As global regulatory pressures mount, the serialization pharmaceutical supply chain has become the backbone of patient safety and brand protection. This guide explores technical implementation, DSCSA compliance, and how CDMOs are leveraging track-and-trace data to optimize logistics in the modern biopharma landscape.

Supply Chain and Logistics
How to Choose the Right CDMO Partner for Your Drug Program

Selecting the right manufacturing partner is a high-stakes decision for any biotech or pharma sponsor. This comprehensive guide explores how to choose a CDMO partner by evaluating technical capabilities, regulatory history, and cultural fit. From initial screening to long-term strategic alignment, learn the essential criteria to ensure your drug program's success.

Outsourcing Outlook
Viral Clearance Studies at Biologics CDMOs: What Regulators Expect

Navigating viral clearance studies biologics cdmo protocols is vital for regulatory approval. This 2500-word guide explores experimental design, virus spiking, and log reduction factors. Discover how biotechs and CDMOs collaborate to demonstrate safety, mitigate adventitious agent risks, and satisfy FDA/EMA expectations in the complex landscape of large-molecule manufacturing.

Testing Matters
Continuous Manufacturing in Pharma: Why CDMOs Are Investing in the Technology

The industry is moving away from batch processing. This guide analyzes continuous manufacturing pharma benefits, including cost efficiency, quality control, and faster timelines. Discover why leading CDMOs are investing in flow technology and what this shift means for sponsors seeking reliable, scalable, and compliant pharmaceutical manufacturing solutions in 2026.

Ai and Automation